Compare Range Nuclear Renaissance ETF (NUKZ) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Range Nuclear Renaissance ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Range Nuclear Renaissance ETF trades at $61.06 (market cap $698.21M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 36.2× Range Nuclear Renaissance ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Range Nuclear Renaissance ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Range Nuclear Renaissance ETF for 18 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| NUKZ | RPRX | |
|---|---|---|
Market Cap | $698.21M | $25.27B |
Volume | 57,444 | 3,671,183 |
Sector | Sector/Thematic | Health |
52-Week High | $76.23 | $63.96 |
52-Week Low | $60.23 | $35.44 |
Typical Hold Time | 18 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Range Nuclear Renaissance ETF
Range Nuclear Renaissance ETF seeks to track companies related to the nuclear energy industry. Its holdings may include businesses involved in uranium, nuclear power generation, reactors, and nuclear services.
Read more on NUKZ →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
